Crispr Therapeutics call volume above normal and directionally bullish

Bullish option flow detected in Crispr Therapeutics (CRSP) with 5,198 calls trading, 1.3x expected, and implied vol increasing over 3 points to 55.13%. Jan-25 50 calls and Dec-24 47 calls are the most active options, with total volume in those strikes near 1,300 contracts. The Put/Call Ratio is 0.20. Earnings are expected on February 19th.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue